Anne Cross, MD, FAAN, professor of neurology at Washington University, who was not involved with the studies, said that, coupled with similar findings from a research group in Germany and an earlier analysis from Dr. Bove’s group, the data on ocrelizumab are “very reassuring.”
Are Ocrelizumab and Ofatumumab Safe During Pregnancy?
View Content